HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Triolein

(Z)-9-Octadecenoic acid 1,2,3-propanetriyl ester.
Also Known As:
Glycerol Trioleate; Trielaidin; Trioleate-Glycerin; Trioleoylglycerol; Trioleyl Glycerol; Glycerol, Trioleyl; Trioleate Glycerin; Trioleate, Glycerol; 9-Octadecenoic acid (Z)-, 1,2,3-propanetriyl ester
Networked: 168 relevant articles (5 outcomes, 16 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kim, Hak Jin: 7 articles (05/2016 - 10/2002)
2. Choi, Seon Hee: 5 articles (05/2016 - 06/2010)
3. Kim, Yong-Woo: 4 articles (05/2016 - 01/2014)
4. Molteni, Agostino: 3 articles (01/2018 - 04/2012)
5. Cho, Byung Mann: 3 articles (05/2016 - 10/2002)
6. Tso, Patrick: 3 articles (04/2015 - 02/2002)
7. Hayashi, Hiroshi: 2 articles (01/2019 - 10/2006)
8. Poisner, Alan M: 2 articles (01/2017 - 04/2012)
9. Yang, Qing: 2 articles (04/2015 - 01/2008)
10. Hwangbo, Lee: 2 articles (12/2014 - 01/2014)

Related Diseases

1. Hemorrhage
2. Body Weight (Weight, Body)
3. Wounds and Injuries (Trauma)
03/01/1979 - "Pulmonary haemodynamic and arterial blood gas changes were measured in dogs subjected to either an intravenous injection of triolein or external trauma, which produced fractures of the ipsilateral femur, tibia and fibula. "
01/01/1979 - "Pulmonary haemodynamic and arterial blood gas changes were measured in dogs subjected to either an intravenous injection of triolein or external trauma, which produced fractures of the ipsilateral femur, tibia and fibula. "
05/01/1976 - "Evidence for consumptive coagulopathy was found in the trauma group but only a mild thrombocytopenia resulted from intravenous triolein. "
05/01/1976 - "Musculoskeletal trauma causes mild arterial hypoxia whereas intravenous pure triolein 0.1 mg/kg does not. "
09/15/2009 - "The results presented, herein, demonstrate for the first time that: 1) the MW of this protein, HDFx, is approximately 35-40 KDa , larger than known defensin peptides and much smaller than the larger MW fibronectins and complement products; 2) we describe some of HDFx's physico-chemical characteristics; 3) approximately 80 % of HDFx's plasma biological activity is derived from macrophages; 4) about 15-20 % of its activity is derived from natural killer (NK) cells; 5) polymorphonuclear leukocytes are not a source of HDFx synthesis or release; 6) known stimulants of the RES-macrophage system (i.e., denatured human serum albumin, triolein, and choline chloride) effect phagocytic stimulation of macrophages and protection against endotoxins, trauma, and hemorrhage via synthesis and release of HDFx; 7) adaptation to lethal trauma is dependent on the biological activity of HDFx; and 8) repeated administration of purified HDFx to rats, over several months, does not produce any detectable pathologies. "
4. Necrosis
5. Chronic Pancreatitis

Related Drugs and Biologics

1. Emulsions
2. Triglycerides (Triacylglycerol)
3. Enzymes
4. Lipoprotein Lipase (Diacylglycerol Lipase)
5. Proteins (Proteins, Gene)
6. Albumins
7. Defensins
8. Peptides (Polypeptides)
9. Fibronectins (Fibronectin)
10. Endotoxins

Related Therapies and Procedures

1. Intravenous Injections
2. Oral Administration
3. Vascular Access Devices (Arterial Line)
4. Bariatric Surgery
5. Caloric Restriction